Oncolytic Viruses: Methods and Protocols
Since the first report of an engineered oncolytic virus, there has been a continuing and steady increase of interest in the field, and while bench research remains vital for the translation of research in this field, its success depends on breakthroughs in clinical studies. Oncolytic Viruses: Method...
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
2012
|
Schriftenreihe: | Methods in Molecular Biology, Methods and Protocols
797 |
Schlagworte: | |
Online-Zugang: | UBR01 TUM01 Volltext |
Zusammenfassung: | Since the first report of an engineered oncolytic virus, there has been a continuing and steady increase of interest in the field, and while bench research remains vital for the translation of research in this field, its success depends on breakthroughs in clinical studies. Oncolytic Viruses: Methods and Protocols describes the construction and purification of capsid-modified adenoviruses as well as oncolytic adenoviruses, presents protocols for many individual virus species including engineering and preparation of oncolytic HSV, propagation, purification, and in vivo testing of oncolytic VSV, details properties of oncolytic reovirus and NDV, and describes the generation and testing of next generation of oncolytic vaccinia virus. As the host immune system plays a critical role in determining efficacy of oncolytic viruses, two chapters are devoted to the study of immune response. Recent advances in stem cell research have led the field in two distinct directions: the use of stem cells as carrier vehicles for oncolytic viruses and the targeting of cancer stem cells. As such, the volume describes the use of explant tissue samples from patients to potentially provide useful information predicting responses prior to clinical translation. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and easily accessible, Oncolytic Viruses: Methods and Protocols seeks to serve both professionals and novices with its well-honed methodologies in an effort to further our knowledge of this essential and vital field |
Beschreibung: | 1 Online-Ressource (X, 241 p. 35 illus., 11 illus. in color) |
ISBN: | 9781617793400 |
DOI: | 10.1007/978-1-61779-340-0 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV044951250 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 180517s2012 |||| o||u| ||||||eng d | ||
020 | |a 9781617793400 |9 978-1-61779-340-0 | ||
024 | 7 | |a 10.1007/978-1-61779-340-0 |2 doi | |
035 | |a (ZDB-2-PRO)978-1-61779-340-0 | ||
035 | |a (OCoLC)1036319375 | ||
035 | |a (DE-599)BVBBV044951250 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-91 | ||
082 | 0 | |a 616.9 |2 23 | |
245 | 1 | 0 | |a Oncolytic Viruses |b Methods and Protocols |c edited by David H. Kirn, Ta-Chiang Liu, Stephen H. Thorne |
264 | 1 | |a Totowa, NJ |b Humana Press |c 2012 | |
300 | |a 1 Online-Ressource (X, 241 p. 35 illus., 11 illus. in color) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Methods in Molecular Biology, Methods and Protocols |v 797 | |
520 | |a Since the first report of an engineered oncolytic virus, there has been a continuing and steady increase of interest in the field, and while bench research remains vital for the translation of research in this field, its success depends on breakthroughs in clinical studies. Oncolytic Viruses: Methods and Protocols describes the construction and purification of capsid-modified adenoviruses as well as oncolytic adenoviruses, presents protocols for many individual virus species including engineering and preparation of oncolytic HSV, propagation, purification, and in vivo testing of oncolytic VSV, details properties of oncolytic reovirus and NDV, and describes the generation and testing of next generation of oncolytic vaccinia virus. As the host immune system plays a critical role in determining efficacy of oncolytic viruses, two chapters are devoted to the study of immune response. Recent advances in stem cell research have led the field in two distinct directions: the use of stem cells as carrier vehicles for oncolytic viruses and the targeting of cancer stem cells. As such, the volume describes the use of explant tissue samples from patients to potentially provide useful information predicting responses prior to clinical translation. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and easily accessible, Oncolytic Viruses: Methods and Protocols seeks to serve both professionals and novices with its well-honed methodologies in an effort to further our knowledge of this essential and vital field | ||
650 | 4 | |a Medicine & Public Health | |
650 | 4 | |a Infectious Diseases | |
650 | 4 | |a Medicine | |
650 | 4 | |a Infectious diseases | |
650 | 0 | 7 | |a Stammzelle |0 (DE-588)4665329-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Adenoviren |0 (DE-588)4141412-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Tumorzelle |0 (DE-588)4186433-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Onkolyse |0 (DE-588)4172588-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Methode |0 (DE-588)4038971-6 |2 gnd |9 rswk-swf |
655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Tumorzelle |0 (DE-588)4186433-5 |D s |
689 | 0 | 1 | |a Stammzelle |0 (DE-588)4665329-6 |D s |
689 | 0 | 2 | |a Onkolyse |0 (DE-588)4172588-8 |D s |
689 | 0 | 3 | |a Adenoviren |0 (DE-588)4141412-3 |D s |
689 | 0 | 4 | |a Methode |0 (DE-588)4038971-6 |D s |
689 | 0 | |8 2\p |5 DE-604 | |
700 | 1 | |a Kirn, David H. |4 edt | |
700 | 1 | |a Liu, Ta-Chiang |4 edt | |
700 | 1 | |a Thorne, Stephen H. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781617793394 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-61779-340-0 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-PRO | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-030344007 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u https://doi.org/10.1007/978-1-61779-340-0 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1007/978-1-61779-340-0 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804178539642093568 |
---|---|
any_adam_object | |
author2 | Kirn, David H. Liu, Ta-Chiang Thorne, Stephen H. |
author2_role | edt edt edt |
author2_variant | d h k dh dhk t c l tcl s h t sh sht |
author_facet | Kirn, David H. Liu, Ta-Chiang Thorne, Stephen H. |
building | Verbundindex |
bvnumber | BV044951250 |
collection | ZDB-2-PRO |
ctrlnum | (ZDB-2-PRO)978-1-61779-340-0 (OCoLC)1036319375 (DE-599)BVBBV044951250 |
dewey-full | 616.9 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.9 |
dewey-search | 616.9 |
dewey-sort | 3616.9 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-61779-340-0 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04188nmm a2200613zcb4500</leader><controlfield tag="001">BV044951250</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180517s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781617793400</subfield><subfield code="9">978-1-61779-340-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-61779-340-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-61779-340-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1036319375</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044951250</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Oncolytic Viruses</subfield><subfield code="b">Methods and Protocols</subfield><subfield code="c">edited by David H. Kirn, Ta-Chiang Liu, Stephen H. Thorne</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 241 p. 35 illus., 11 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Molecular Biology, Methods and Protocols</subfield><subfield code="v">797</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Since the first report of an engineered oncolytic virus, there has been a continuing and steady increase of interest in the field, and while bench research remains vital for the translation of research in this field, its success depends on breakthroughs in clinical studies. Oncolytic Viruses: Methods and Protocols describes the construction and purification of capsid-modified adenoviruses as well as oncolytic adenoviruses, presents protocols for many individual virus species including engineering and preparation of oncolytic HSV, propagation, purification, and in vivo testing of oncolytic VSV, details properties of oncolytic reovirus and NDV, and describes the generation and testing of next generation of oncolytic vaccinia virus. As the host immune system plays a critical role in determining efficacy of oncolytic viruses, two chapters are devoted to the study of immune response. Recent advances in stem cell research have led the field in two distinct directions: the use of stem cells as carrier vehicles for oncolytic viruses and the targeting of cancer stem cells. As such, the volume describes the use of explant tissue samples from patients to potentially provide useful information predicting responses prior to clinical translation. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and easily accessible, Oncolytic Viruses: Methods and Protocols seeks to serve both professionals and novices with its well-honed methodologies in an effort to further our knowledge of this essential and vital field</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine & Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infectious Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infectious diseases</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Stammzelle</subfield><subfield code="0">(DE-588)4665329-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Adenoviren</subfield><subfield code="0">(DE-588)4141412-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumorzelle</subfield><subfield code="0">(DE-588)4186433-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Onkolyse</subfield><subfield code="0">(DE-588)4172588-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Methode</subfield><subfield code="0">(DE-588)4038971-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Tumorzelle</subfield><subfield code="0">(DE-588)4186433-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Stammzelle</subfield><subfield code="0">(DE-588)4665329-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Onkolyse</subfield><subfield code="0">(DE-588)4172588-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Adenoviren</subfield><subfield code="0">(DE-588)4141412-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Methode</subfield><subfield code="0">(DE-588)4038971-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kirn, David H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Ta-Chiang</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thorne, Stephen H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781617793394</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-61779-340-0</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030344007</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-61779-340-0</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-61779-340-0</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV044951250 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:05:35Z |
institution | BVB |
isbn | 9781617793400 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030344007 |
oclc_num | 1036319375 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (X, 241 p. 35 illus., 11 illus. in color) |
psigel | ZDB-2-PRO |
publishDate | 2012 |
publishDateSearch | 2012 |
publishDateSort | 2012 |
publisher | Humana Press |
record_format | marc |
series2 | Methods in Molecular Biology, Methods and Protocols |
spelling | Oncolytic Viruses Methods and Protocols edited by David H. Kirn, Ta-Chiang Liu, Stephen H. Thorne Totowa, NJ Humana Press 2012 1 Online-Ressource (X, 241 p. 35 illus., 11 illus. in color) txt rdacontent c rdamedia cr rdacarrier Methods in Molecular Biology, Methods and Protocols 797 Since the first report of an engineered oncolytic virus, there has been a continuing and steady increase of interest in the field, and while bench research remains vital for the translation of research in this field, its success depends on breakthroughs in clinical studies. Oncolytic Viruses: Methods and Protocols describes the construction and purification of capsid-modified adenoviruses as well as oncolytic adenoviruses, presents protocols for many individual virus species including engineering and preparation of oncolytic HSV, propagation, purification, and in vivo testing of oncolytic VSV, details properties of oncolytic reovirus and NDV, and describes the generation and testing of next generation of oncolytic vaccinia virus. As the host immune system plays a critical role in determining efficacy of oncolytic viruses, two chapters are devoted to the study of immune response. Recent advances in stem cell research have led the field in two distinct directions: the use of stem cells as carrier vehicles for oncolytic viruses and the targeting of cancer stem cells. As such, the volume describes the use of explant tissue samples from patients to potentially provide useful information predicting responses prior to clinical translation. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and easily accessible, Oncolytic Viruses: Methods and Protocols seeks to serve both professionals and novices with its well-honed methodologies in an effort to further our knowledge of this essential and vital field Medicine & Public Health Infectious Diseases Medicine Infectious diseases Stammzelle (DE-588)4665329-6 gnd rswk-swf Adenoviren (DE-588)4141412-3 gnd rswk-swf Tumorzelle (DE-588)4186433-5 gnd rswk-swf Onkolyse (DE-588)4172588-8 gnd rswk-swf Methode (DE-588)4038971-6 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Tumorzelle (DE-588)4186433-5 s Stammzelle (DE-588)4665329-6 s Onkolyse (DE-588)4172588-8 s Adenoviren (DE-588)4141412-3 s Methode (DE-588)4038971-6 s 2\p DE-604 Kirn, David H. edt Liu, Ta-Chiang edt Thorne, Stephen H. edt Erscheint auch als Druck-Ausgabe 9781617793394 https://doi.org/10.1007/978-1-61779-340-0 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Oncolytic Viruses Methods and Protocols Medicine & Public Health Infectious Diseases Medicine Infectious diseases Stammzelle (DE-588)4665329-6 gnd Adenoviren (DE-588)4141412-3 gnd Tumorzelle (DE-588)4186433-5 gnd Onkolyse (DE-588)4172588-8 gnd Methode (DE-588)4038971-6 gnd |
subject_GND | (DE-588)4665329-6 (DE-588)4141412-3 (DE-588)4186433-5 (DE-588)4172588-8 (DE-588)4038971-6 (DE-588)4143413-4 |
title | Oncolytic Viruses Methods and Protocols |
title_auth | Oncolytic Viruses Methods and Protocols |
title_exact_search | Oncolytic Viruses Methods and Protocols |
title_full | Oncolytic Viruses Methods and Protocols edited by David H. Kirn, Ta-Chiang Liu, Stephen H. Thorne |
title_fullStr | Oncolytic Viruses Methods and Protocols edited by David H. Kirn, Ta-Chiang Liu, Stephen H. Thorne |
title_full_unstemmed | Oncolytic Viruses Methods and Protocols edited by David H. Kirn, Ta-Chiang Liu, Stephen H. Thorne |
title_short | Oncolytic Viruses |
title_sort | oncolytic viruses methods and protocols |
title_sub | Methods and Protocols |
topic | Medicine & Public Health Infectious Diseases Medicine Infectious diseases Stammzelle (DE-588)4665329-6 gnd Adenoviren (DE-588)4141412-3 gnd Tumorzelle (DE-588)4186433-5 gnd Onkolyse (DE-588)4172588-8 gnd Methode (DE-588)4038971-6 gnd |
topic_facet | Medicine & Public Health Infectious Diseases Medicine Infectious diseases Stammzelle Adenoviren Tumorzelle Onkolyse Methode Aufsatzsammlung |
url | https://doi.org/10.1007/978-1-61779-340-0 |
work_keys_str_mv | AT kirndavidh oncolyticvirusesmethodsandprotocols AT liutachiang oncolyticvirusesmethodsandprotocols AT thornestephenh oncolyticvirusesmethodsandprotocols |